Table 1. Distribution of 22 Studies Under Assessment, Both Drug Wise and Study Design Wise.
| Drugs/therapy | Study design |
Total | |||
|---|---|---|---|---|---|
| Clinical trial | Case series | Case report | Observational study | ||
| HCQ/CQ with macrolide (azithromycin/clarithromycin) | 1 | 1 | 1 | 3 | |
| HCQ | 2 | 1 | 2 | 5 | |
| Lopinavir/ritonavir | 1 | 1 | 2 | 4 | |
| Umifenovir/favipiravir | 1 | 1 | |||
| Methylprednisolone (with other agent) | 1 | 1 | 2 | ||
| Thalidomide with methylprednisolone | 1 | 1 | |||
| Remdesivir | 2 | 1 | 3 | ||
| Interferon (in combination) | 1 | 1 | 1 | 3 | |
| Total | 8 | 3 | 4 | 7 | 22 |
HCQ: hydroxychloroquine; CQ: chloroquine.